For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your country/region into the box below, to view site information related to your country/region.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Access advice and support for any research roadblock
View support hub
Your experiments laid out step by step
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
Supporting our customers and employees during the COVID-19 pandemic. Read more
Analyze FirePlex® multiplex assays on your flow cytometer. Sensitive and accurate with no need for a dedicated instrument.
Explore the complex pathology of stroke and access the tools you need to advance your research in stroke and its associated diseases.
The cytokines and co-culture feeder cells you need to differentiate hESCs into mature myeloid and lymphoid cells.
Read our review of the history of toll-like receptors and their role in innate immunity.
Check out our newest product releases for Immuno-oncology to further your research.
Complete guide to selecting NF-kB inhibitors and activators.
Read an overview of beta-amyloid and tau in Alzheimer's and access the tools you need to better understand the role they play within this complex condition.
FirePlex® particle technology works with your flow cytometer to allow true multiplexed analysis. Find out how others have been using the technology.
Everything you need to study the type III intermediate protein, vimentin.
CRISPR-edited cells can be used in a variety of assays. Recent case studies from the drug discovery world show how this technology is being applied to the pipeline today.